Pricing Guide

Zepbound Cost

Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Zepbound Cost is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Zepbound Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.

Key Fact

Weight Method's compounded tirzepatide program is $329/month, all-inclusive, with no insurance required. Weight Method does not dispense brand-name Zepbound®. Compounded tirzepatide is not FDA-approved; published brand-name clinical-trial outcomes do not describe the compounded product.

Source: Weight Method pricing, February 2026

How much does treatment cost per month?

Zepbound's pricing from Eli Lilly is uniform across all dose levels — patients starting at 2.5mg pay the same as those at the maximum 15mg. At retail pharmacies, the actual cash price may vary slightly by location and dispensing fee. For patients with insurance coverage for Zepbound, the cost pathway still involves significant out-of-pocket expenses. Annual deductibles must be met first, and specialty tier copays apply on top of that, so accumulated annual out-of-pocket costs can remain high even with coverage. Weight Method's $329/month compounded tirzepatide is a flat all-inclusive monthly fee that does not vary by dose. There is no enrollment fee, no annual cost reset, and no dose-based price increase. Compounded tirzepatide is not FDA-approved.

How can you save on treatment?

Weight Method's compounded tirzepatide program is a flat $329/month all-inclusive fee. Brand-name Zepbound purchased cash-pay at a retail pharmacy is set by Eli Lilly and is a much larger monthly outlay for patients without coverage. The decision between them is not purely financial — Zepbound is FDA-approved (with the FDA review process that designation entails), while compounded tirzepatide is not. Published clinical-trial outcomes describe brand-name Zepbound. Those outcomes were generated with the FDA-approved product and should not be assumed to apply to compounded tirzepatide, which is not FDA-evaluated. Your provider can discuss what to expect from compounded therapy based on your individual clinical profile. Weight Method's compounded tirzepatide program bundles medication, provider consultations, dose adjustments, and home delivery into one predictable monthly cost — eliminating the incidental expenses (specialist visits, lab work, dispensing fees) of the conventional pathway.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Brand-name Zepbound purchased cash-pay at a retail pharmacy is set by the manufacturer and is a significant monthly cost without coverage. Weight Method's compounded tirzepatide program is $329/month, all-inclusive, with no insurance required. Zepbound is FDA-approved for chronic weight management; compounded tirzepatide is not FDA-approved.

Coverage of FDA-approved Zepbound is limited and evolving. Many insurers have not yet added Zepbound to their formularies. When covered, prior authorization is required and specialty tier copays are typical.

Both are FDA-approved Eli Lilly products containing tirzepatide. Zepbound® is FDA-approved for chronic weight management; Mounjaro® is FDA-approved for type 2 diabetes. Same active ingredient and mechanism, different labeled indications and dose ranges.

Published clinical-trial data describes brand-name Zepbound — the FDA-approved product, which the FDA reviewed for safety, efficacy, and manufacturing quality. Compounded tirzepatide is a different product and is not FDA-evaluated; those brand-name trial outcomes do not describe it. Your provider can discuss what to expect from compounded therapy based on your individual clinical profile.

No. Zepbound® is the FDA-approved brand-name medication manufactured by Eli Lilly. Compounded tirzepatide is prepared by a U.S.-licensed 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality.

Get GLP-1 at the Best Price

We offer the most affordable GLP-1 treatments. Starting at $199/month.

See Pricing

Free consultation. No commitment.

Other Cost Guides

Semaglutide CostTirzepatide CostOzempic CostWegovy CostMounjaro CostGLP-1 Medication CostWeight Loss Medication Cost

Zepbound Cost by State

Zepbound Cost in AlabamaZepbound Cost in AlaskaZepbound Cost in ArizonaZepbound Cost in ArkansasZepbound Cost in CaliforniaZepbound Cost in ColoradoZepbound Cost in ConnecticutZepbound Cost in Delaware